Predicting progression to AIDS. An evaluation of two approaches

Area of Science:

• Immunology
• Infectious Diseases
• Clinical Medicine

Background:

• Clinical staging systems are crucial for managing HIV infection.
• Evaluating the predictive validity of existing systems is essential for patient care.
• CD4 count is a primary biomarker, but its predictive power may be enhanced by staging.

Purpose of the Study:

• To assess the predictive validity of the Rabeneck and Royce clinical staging systems for HIV infection.
• To determine if these staging systems predict progression to Acquired Immunodeficiency Syndrome (AIDS).
• To compare the prognostic utility of clinical staging systems against CD4 count alone.

Main Methods:

• Utilized data from the Department of Veterans Affairs Cooperative Study Number 298, a randomized clinical trial.
• Included 335 symptomatic HIV patients with CD4 counts between 200 and 500/mm3.
• Employed Kaplan-Meier estimates and Cox proportional hazards models to analyze progression to AIDS.

Main Results:

• Both the Rabeneck and Royce staging systems were significant independent predictors of progression to AIDS.
• Clinical staging provided greater prognostic distinction compared to CD4 count alone.
• The study confirmed the predictive validity of these simple staging systems.

Conclusions:

• Simple clinical staging systems for HIV infection can offer significant prognostic value.
• The Rabeneck and Royce systems demonstrate utility in predicting AIDS progression.
• These staging systems can complement CD4 counts for improved patient prognostication.